Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-069969
Filing Date
2015-09-09
Accepted
2015-09-09 17:31:44
Documents
1
Period of Report
2015-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7476
  Complete submission text file 0001209191-15-069969.txt   8907
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2656 CROSSPARK ROAD SUITE 100 CORALVILLE IA 52241
Business Address
Mickle Travis C (Reporting) CIK: 0001638365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 151099600